Zinc Oxide, Octisalate, Homosalate
Generic Name: zinc oxide, octisalate, homosalate
Brand Names:
Dr.g Bright Toning Up Tinted Sunscreen
Purpose Sunscreen
Overview
Purpose Sunscreen
Uses
Use Helps prevent sunbum. If used as directed with other sun protection measures (see Directions ) decreases the risk of skin cancer and early skin aging caused by the sun.
Dosage
Directions Apply liberally 15 minutes before sun exposure. Reapply at least every 2 hours. Use a water resistant sunscreen if swimming or sweating. Children under 6 months: Ask a doctor. Sun Protection Measures Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease risk, regularly use a sunscreen with a Broad Spectrum SPF value of 15 or higher and other sun protection measures including: Limit time in the sun, especially from 10 am .- 2 p.m. Wear long sleeved shirts, pants, hats and sunglasses.
Warnings
Warnings For external use only. Do not use on damaged or broken skin. When using this product keep out of eyes. Rinse with water to remove. Stop use and ask a doctor if rash occurs.
Frequently Asked Questions
What is Zinc Oxide, Octisalate, Homosalate used for?▼
Use Helps prevent sunbum. If used as directed with other sun protection measures (see Directions ) decreases the risk of skin cancer and early skin aging caused by the sun.
What are the important warnings for Zinc Oxide, Octisalate, Homosalate?▼
Warnings For external use only. Do not use on damaged or broken skin. When using this product keep out of eyes. Rinse with water to remove. Stop use and ask a doctor if rash occurs.
Related Medications
Patritumab
patritumab
Dosage form: LIQUID. Active ingredients: PATRITUMAB (70 g/70g). Category: BULK INGREDIENT.
Ciprofloxacin Otic Solution, 0.2%
ciprofloxacin otic solution, 0.2%
Fluoroquinolone Antibacterial [EPC]
11 DESCRIPTION Ciprofloxacin otic solution, 0.2% contains the synthetic antimicrobial agent ciprofloxacin hydrochloride. Ciprofloxacin otic solution, 0.2% is a sterile, preservative-free solution for otic use. Each single-dose container of ciprofloxacin otic solution, 0.2% delivers 0.25 mL of solution equivalent to 0.5 mg of ciprofloxacin. The inactive ingredients are povidone, glycerin, and water for injection. Sodium hydroxide and/or lactic acid may be added to adjust pH.
Oral Semaglutide
oral semaglutide
GLP-1 Receptor Agonist [EPC]
11 DESCRIPTION RYBELSUS and OZEMPIC tablets, for oral use, contain semaglutide, a GLP-1 receptor agonist. The peptide backbone is produced by yeast fermentation. The main protraction mechanism of semaglutide is albumin binding, facilitated by modification of position 26 lysine with a hydrophilic spacer and a C18 fatty di-acid. Furthermore, semaglutide is modified in position 8 to provide stabilization against degradation by the enzyme dipeptidyl-peptidase 4 (DPP-4).
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.